Miracell to Participate in KIMES 2022 with Advanced Stem Cell Medical Devices
Extraction of large quantities of stem cells through centrifugation with minimal manipulation
Miracell announced on the 6th that it plans to participate in the medical device exhibition “KIMES 2022.”
The 37th Korea International Medical & Hospital Equipment Show (KIMES 2022) will be held for four days from the 10th to the 13th,
under the theme “KIMES, Where New Hope Begins.”
Miracell’s “Smart M-cell 2” is a cutting-edge regenerative medical bio-device that extracts large quantities of stem cells through centrifugation with minimal manipulation,
enriched and automatically separated.
The company explained that the device, a “bone marrow and blood stem cell extraction device including a centrifuge vessel capable of selective separation,”
has received approval from the Ministry of Food and Drug Safety and certification as a new medical technology by the Ministry of Health and Welfare.
Stem cells have recently been recognized for their limitless benefits in cartilage defects, pain management, preventive medicine, and holistic healthcare, attracting increasing interest from medical professionals and industry professionals.
Miracell’s Cellpia Global Platform (CGP) shares stem cell medical technology through a network of member hospitals and clinics. CGP provides education, technology transfer, medical equipment setup, and marketing to hospitals in Korea and abroad to ensure safer stem cell regenerative medicine treatments.
A company representative explained, “Miracell’s CGP hospitals are located in major cities across the country, including Daejeon, Daegu, Gwangju, Ulsan, and Busan, in addition to the Seoul metropolitan area, offering orthopedic, plastic, dermatological, urological, obstetrics and gynecological, and family medicine services.”
By Sangjun Ahn ansang@viva100.com